Principal Healthcare Innovators ETF | TalkMarkets

Latest Posts

Biotech ETFs To Benefit From Latest Booster Update

Article By: Zacks Investment Research

Saturday, August 21, 2021 3:59 PM EDT

Vaccine makers like Moderna and Pfizer have reasons to cheer the update with regard to the application of boosters. The U.S. government announced plans to make COVID-19 vaccine boosters available from Sept. 20 onward. Here's ETFs that may benefit.

In this article: IBB, BBH, FBT, XBI, BTEC Also: PFE, MRNA, BNTX

Read

Biotech ETFs To Suffer As US Backs IP Waiver For COVID-19 Vaccines

Article By: Zacks Investment Research

Saturday, May 8, 2021 6:01 PM EDT

The Biden administration announced support for the waiver of intellectual property protections for COVID-19 vaccines proposed by South Africa and India. Let’s take a look at ETFs that can suffer from the recent development:

In this article: IBB, BBH, XBI, FBT, BTEC Also: AZN, JNJ, PFE, MRNA

Read

Moderna ETFs To Shine On Vaccine News As Outbreak Worsens

Article By: Zacks Investment Research

Wednesday, November 18, 2020 4:55 AM EDT

The first company to begin human clinical trials of its coronavirus vaccine candidate in the United States — Moderna — has once again come up with encouraging study data relating to mRNA-1273.

In this article: IBB, BBH, XBI, BTEC, IDNA, GERM, MRNA

Read

Moderna ETFs To Gain On New Positive COVID-19 Vaccine Data

Article By: Zacks Investment Research

Friday, August 28, 2020 6:31 PM EDT

The competition to come up with a coronavirus vaccine is opening up near-term opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide exposure to Moderna.

In this article: IBB, BBH, XBI, MRNA, CNCR, BTEC, IDNA, GERM

Read